MetaCap

111 Inc. ADR (YI)

NASDAQ: YIConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD

2.36-0.15 (-5.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

YI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$20.76M
EPS (TTM)
$10.26
52-week range
2.34 – 11.17
Day range
2.34 – 2.67
Volume / Avg
19.47K / 15.93K
Beta
—
Next earnings
Dec 16, 2026

52-week range

$2.34$11.17

YI stock today

111 (YI) closed at $2.36 on Nov 20, down 5.98% (-$0.15), versus the S&P 500's 3.70% decline. At this level, YI sits near the bottom of its 52-week range of $2.34 to $11.17: 78.9% below the high, set on Jan 30, 2026 and 0.9% above the low. YI is down 7.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 35.5%.

111 trades at 0.2x its trailing twelve-month earnings per share of $10.26. Its forward P/E of 16.9x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. 111's next earnings report is expected on Dec 16, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About 111

Company profile

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services.

Industry
Retail-Drug Stores and Proprietary Stores
CEO
Mr. Junling Liu
Headquarters
Shanghai
Employees
1,063
IPO year
2018

Financial highlights

Full financials

In fiscal 2025, 111 generated $1.80 billion in revenue, down 9.0% from fiscal 2024, its first annual decline since 2024. 111 reported a net loss of $3.2 million, compared with a loss of $2.8 million a year earlier. Gross margin was 5.8% (flat year over year) and operating margin -0.0%.

111 annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.80B$1.97B$2.11B$1.96B$1.95B
Growth-9.00%-6.29%+7.43%+0.50%+55.10%
Net income$-3.22M$-2.85M$-49.78M$-54.53M$-97.45M
EPS (diluted)$-0.05$-0.05$-0.33$-0.36$-0.63

Earnings

Earnings history
Next report
Dec 16, 2026

YI news

All YI news

111 peers

Consumer Staples sector
YI peer companies
CompanyPrice% ChgMarket capCompare
PETSPetMed Express Inc.0.8501-8.04%$18.90Mvs YI
RDGTRidgetech Inc.0.94-7.44%$3.41Mvs YI
GRDNGuardian Pharmacy Services Inc. Class A46.94+0.58%$2.97Bvs YI
CVSCVS Health Corporation80.84+1.00%$103.43Bvs YI

Indexes, lists and sector

111 stock FAQ

What is 111's stock price today?

YI last traded at $2.36 as of Nov 20, 4:00 PM EST, down 5.98% on the day. Prices are delayed at least 15 minutes.

When is 111's next earnings date?

111 is expected to report earnings on Wednesday, December 16, 2026.

What is YI's P/E ratio?

YI trades at a trailing P/E ratio of 0.23 and a forward P/E of 16.86.

Who is 111's CEO?

Mr. Junling Liu is the chief executive officer of 111 Inc. ADR, which has about 1,063 employees.

What is the YI 52-week high?

The 52-week high for YI is $11.17 and the 52-week low is $2.34. The stock is currently 78.9% below its high.

Compare YI